
BioLife Solutions BLFS
$ 25.08
0.72%
Quarterly report 2025-Q3
added 11-06-2025
BioLife Solutions P/E Ratio 2011-2025 | BLFS
Annual P/E Ratio BioLife Solutions
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -56.4 | -10.9 | -6.71 | -129 | 522 | -172 | 65.4 | -28.6 | -3.31 | -0.00636 | -5.75 | -36.4 | -10.5 | -2.14 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 522 | -172 | 9 |
P/E Ratio of other stocks in the Medical instruments industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Baxter International
BAX
|
-33.7 | $ 19.27 | -0.62 % | $ 9.83 B | ||
|
Becton, Dickinson and Company
BDX
|
33.5 | $ 195.4 | -0.46 % | $ 56.2 B | ||
|
Luminex Corporation
LMNX
|
83.5 | - | - | $ 1.75 B | ||
|
Ekso Bionics Holdings
EKSO
|
-0.854 | $ 5.47 | -1.7 % | $ 110 M | ||
|
Akers Biosciences, Inc.
AKER
|
-0.046 | - | -9.52 % | $ 20.6 M | ||
|
Harvard Bioscience
HBIO
|
-55 | $ 0.67 | -5.25 % | $ 28.4 M | ||
|
Antares Pharma, Inc.
ATRS
|
12.9 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
166 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
-6.23 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
27.2 | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
37.5 | - | -0.02 % | $ 16.3 B | ||
|
LeMaitre Vascular
LMAT
|
47 | $ 82.97 | -0.97 % | $ 1.86 B | ||
|
Repro Med Systems
KRMD
|
-7.04 | $ 6.09 | -2.25 % | $ 278 M | ||
|
Alcon
ALC
|
113 | $ 80.43 | 0.09 % | $ 40.4 B | ||
|
iRhythm Technologies
IRTC
|
-30.8 | $ 177.47 | 0.49 % | $ 5.54 B | ||
|
Masimo Corporation
MASI
|
-29.4 | $ 131.08 | -1.27 % | $ 6.99 B | ||
|
ICU Medical
ICUI
|
-31 | $ 147.16 | -0.48 % | $ 3.59 B | ||
|
Merit Medical Systems
MMSI
|
49.4 | $ 88.6 | 1.38 % | $ 5.16 B | ||
|
AtriCure
ATRC
|
-42.7 | $ 40.56 | 0.57 % | $ 1.9 B | ||
|
Atrion Corporation
ATRI
|
32.9 | - | - | $ 810 M | ||
|
electroCore
ECOR
|
-0.00156 | $ 4.87 | -1.62 % | $ 26.9 K | ||
|
Isoray
ISR
|
-0.309 | - | 0.03 % | $ 108 M | ||
|
AngioDynamics
ANGO
|
-10.4 | $ 12.91 | -1.45 % | $ 527 M | ||
|
The Cooper Companies
COO
|
43.5 | $ 82.13 | -0.59 % | $ 16.4 B | ||
|
Glaukos Corporation
GKOS
|
-32 | $ 115.46 | -0.88 % | $ 5.59 B | ||
|
Haemonetics Corporation
HAE
|
18.3 | $ 80.61 | 0.39 % | $ 4.06 B | ||
|
InfuSystem Holdings
INFU
|
8.11 K | $ 8.92 | -0.45 % | $ 184 M | ||
|
OraSure Technologies
OSUR
|
-13.3 | $ 2.45 | 1.24 % | $ 182 M | ||
|
ResMed
RMD
|
45 | $ 243.61 | -0.51 % | $ 35.6 B | ||
|
Intuitive Surgical
ISRG
|
87.5 | $ 575.51 | -0.4 % | $ 204 B | ||
|
Microbot Medical
MBOT
|
-1.09 | $ 2.11 | -1.86 % | $ 21.5 M | ||
|
STERIS plc
STE
|
39.3 | $ 256.62 | 0.54 % | $ 25.3 B | ||
|
Milestone Scientific
MLSS
|
-14.7 | $ 0.29 | 1.17 % | $ 23.1 M | ||
|
Nephros
NEPH
|
-14.3 | $ 4.9 | -0.61 % | $ 50.9 M | ||
|
NeuroMetrix
NURO
|
-1.12 | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
-3.29 | $ 21.9 | -0.41 % | $ 3.77 B | ||
|
Predictive Oncology
POAI
|
-0.655 | - | - | $ 32.4 M | ||
|
Stereotaxis
STXS
|
-10.4 | $ 2.3 | -6.33 % | $ 186 M | ||
|
Pro-Dex
PDEX
|
16.8 | $ 40.16 | 1.8 % | $ 132 M | ||
|
Utah Medical Products
UTMD
|
57.7 | $ 57.8 | 1.85 % | $ 210 M | ||
|
Pulse Biosciences
PLSE
|
-9.91 | $ 14.25 | -1.04 % | $ 685 M | ||
|
Repligen Corporation
RGEN
|
0.303 | $ 165.7 | -0.31 % | $ 9.23 M | ||
|
Retractable Technologies
RVP
|
-1.76 | $ 0.8 | -4.17 % | $ 23.9 M | ||
|
STAAR Surgical Company
STAA
|
-41.2 | $ 23.44 | 0.36 % | $ 1.15 B | ||
|
Teleflex Incorporated
TFX
|
89.2 | $ 122.42 | -0.31 % | $ 5.73 B | ||
|
West Pharmaceutical Services
WST
|
31.3 | $ 275.14 | 0.19 % | $ 20.1 B | ||
|
DENTSPLY SIRONA
XRAY
|
-3.85 | $ 11.22 | -2.59 % | $ 2.28 B |